Qiming U.S. Ventures Management as of Dec. 31, 2022
Portfolio Holdings for Qiming U.S. Ventures Management
Qiming U.S. Ventures Management holds 7 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Icosavax | 36.9 | $28M | 3.5M | 7.94 | |
| Ventyx Biosciences (VTYX) | 32.4 | $25M | 746k | 32.79 | |
| Hillevax | 12.4 | $9.4M | 559k | 16.73 | |
| Kezar Life Sciences | 7.7 | $5.8M | 829k | 7.04 | |
| Talaris Therapeutics | 4.0 | $3.0M | 2.9M | 1.02 | |
| Jasper Therapeutics | 3.7 | $2.8M | 5.9M | 0.48 | |
| Elevation Oncology (ELEV) | 3.0 | $2.3M | 2.4M | 0.95 |
